Renita Medical raises seed funding
Renita Medical Oy, a healthtech company, has received seed funding which provides it with resources to finalize development and bring it to commercial launch.
Renita Medical is building a personalized brain health solution. The company’s AI-based software, the RENITA platform, uses a patient’s own functional brain activity and combines it with proven cognitive assessment tools to provide a comprehensive and objective report, from which doctors can base their neurological diagnosis. The platform will enhance the neurological diagnosis process and will offer an efficient way to monitor brain health.
Oaklins’ team in Finland acted as the financial advisor in this transaction.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more